ELANE and acute respiratory distress syndrome: In addition, we treated the mice with Sivelestat, an inhibitor of neutrophil elastase, and observed an increase in survival, with just 15% of mice showing pulmonary involvement (compared with the 75% of untreated mice that died of ALI/ARDS) (Fig 7F).